ArticleiScience2025
ProCV: A 3D similarity grouping method for enhanced protein pocket recognition and ligand interaction analysis.
Article in iScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Efficient identification of protein binding pockets is critical for accurately predicting protein-ligand interactions. Traditional sequence-based methods often fail to capture structural complexity and require extensive conformational sampling, limiting both efficiency and accuracy. To overcome these challenges, we present ProCV, an innovative structure-based prediction method that utilizes advanced spatial recognition techniques-specifically, 3D similarity grouping in the Hough space-to enhance precision and speed. ProCV employs uniform spatial sampling, KD-tree structures, and the 3D Hough transform for accurate binding pocket identification. Comparative analyses on datasets from the Protein DataBank (PDB), scPDB, and BioLip demonstrate that ProCV offers high specificity and sensitivity with reduced false positives. Its similarity assessment framework accurately characterizes the spatial arrangement of 3D protein structures, facilitating precise binding site localization. These findings highlight ProCV's robustness, precision, and flexibility in identifying binding residues at atomic resolution within 3D structures, affirming its value in structural bioinformatics for protein-ligand interaction studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.